Non-CNS pathogenic origin of Parkinson's disease

被引:9
|
作者
Choudhry, Humdoon [1 ]
Perlmuter, Lawrence C. [2 ]
机构
[1] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, N Chicago, IL USA
[2] Rosalind Franklin Univ Med & Sci, Dept Psychol, 3333 Green Bay Rd, N Chicago, IL 60064 USA
关键词
Parkinson's disease; Braak's "dual-hit" hypothesis; Gut microbes; Vagus nerve; Alpha-synuclein; Peripheral alpha-synucleinopathy; ALPHA-SYNUCLEIN; BRAIN PATHOLOGY; APPENDECTOMY; RISK; NEUROINVASION; HYPOTHESIS; BIOMARKER;
D O I
10.1007/s00415-017-8588-7
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The gut with its variety of microbiota may serve as an etiological origin of diseases. Gut microbes may also play a role in the pathogenesis of diseases beyond their simple nutritional maintenance and support. For example, gut protein aggregation, possibly aided by microbes as well as nasal influences, might be linked to disease that may move to the brain through the vagus nerve. To this end, Braak has offered a "dual-hit" hypothesis that proposes a novel etiology for Parkinson's disease (PD). The hypothesis places the initial origin of the disease in the nose and the gastrointestinal tract (GI) after infection by an unknown pathogen that could aggregate in the gut and then eventually spread to the brain via the autonomic plexuses. Gut health functioning, therefore, may affect brain status and behavior. A protein known as alpha-synuclein accumulates in brains of people with Parkinson's disease that is also present in the GI before the onset of motor symptoms. Therefore, the stomach, previously thought to be a stable mechanism throughout life, might explain some etiological origins of disease. Finally, the vagus nerve of the autonomic system that extends from the brain to the abdomen and exercises both sympathetic and parasympathetic roles might be associated with PD diagnosis along with Lewy body influences.
引用
收藏
页码:2027 / 2030
页数:4
相关论文
共 50 条
  • [31] Nicotinic receptors as CNS targets for Parkinson's disease
    Quik, Maryka
    Bordia, Tanuja
    O'Leary, Kathryn
    BIOCHEMICAL PHARMACOLOGY, 2007, 74 (08) : 1224 - 1234
  • [32] Segregated graft-versus-tumor effect between CNS and non-CNS lesions of Ewing's sarcoma familyof tumors
    Hosono, A.
    Makimoto, A.
    Kawai, A.
    Takaue, Y.
    BONE MARROW TRANSPLANTATION, 2008, 41 (12) : 1067 - 1068
  • [33] Imaging aspects of neurologic emergencies in children treated for non-CNS malignancies
    Kaste, SC
    Rodriguez-Galindo, C
    Furman, WL
    Langston, J
    Thompson, SJ
    PEDIATRIC RADIOLOGY, 2000, 30 (08) : 558 - 565
  • [34] Toward preventing Parkinson's disease A glycoprotein is a possible biomarker of pathogenic progression for Parkinson's disease
    Mollenhauer, Brit
    von Arnim, Christine A. F.
    SCIENCE, 2022, 377 (6608) : 818 - 819
  • [35] Mitophagy in Parkinson's Disease: Pathogenic and Therapeutic Implications
    Gao, Fei
    Yang, Jia
    Wang, Dongdong
    Li, Chao
    Fu, Yi
    Wang, Huaishan
    He, Wei
    Zhang, Jianmin
    FRONTIERS IN NEUROLOGY, 2017, 8
  • [36] No pathogenic mutations in the persyn gene in Parkinson's disease
    Lincoln, S
    Gwinn-Hardy, K
    Goudreau, J
    Chartier-Harlin, MC
    Baker, M
    Mouroux, V
    Richard, F
    Destée, A
    Becquet, E
    Amouyel, P
    Lynch, T
    Hardy, J
    Farrer, M
    NEUROSCIENCE LETTERS, 1999, 259 (01) : 65 - 66
  • [37] Pathogenic role of glial cells in Parkinson's disease
    Teismann, P
    Tieu, K
    Cohen, O
    Choi, DK
    Wu, DC
    Marks, D
    Vila, M
    Jackson-Lewis, V
    Przedborski, S
    MOVEMENT DISORDERS, 2003, 18 (02) : 121 - 129
  • [38] No pathogenic mutations in the β-synuclein gene in Parkinson's disease
    Lincoln, S
    Crook, R
    Chartier-Harlin, MC
    Gwinn-Hardy, K
    Baker, M
    Mouroux, V
    Richard, F
    Becquet, E
    Amouyel, P
    Destée, A
    Hardy, J
    Farrer, M
    NEUROSCIENCE LETTERS, 1999, 269 (02) : 107 - 109
  • [39] Are neurologic symptoms associated with worse QoL in non-CNS cancer patients?
    Cacho-Diaz, Bernardo
    Gonzalez-Gonzalez, Ethan
    Bonilla-Navarrete, Andres Mauricio
    Texcocano-Becerra, Julia
    Onate-Ocana, Luis F.
    JOURNAL OF CLINICAL NEUROSCIENCE, 2023, 111 : 39 - 45
  • [40] COGNITIVE EFFECTS OF NON-CNS DIRECTED CHEMOTHERAPY IN SURVIVORS OF CHILDHOOD CANCER
    Schagen, Sanne
    Sprenger, Gregory
    Deijen, Jan-Berend
    van den Bos, Cor
    Grootenhuis, Martha
    Buizer, Annemieke
    PEDIATRIC BLOOD & CANCER, 2011, 56 (07) : 1158 - 1158